Review Of Related Disease (RRD) 4 Practice Exam

Vaccines train the adaptive immune system to recognize specific pathogens by producing targeted antibodies and memory cells, so the body can respond quickly if exposed again. This is not primarily about mucosal immunity; MMR mainly induces systemic antibody and T-cell responses that persist for most people, though antibody levels can eventually decline and protection can wane over time in some cases. After vaccination, circulating antibodies and memory cells provide protection. Boosters are used when immunity may weaken enough that exposure could lead to disease, or to ensure protection across a population, such as completing the two-dose MMR schedule. For MMR, the typical schedule includes two doses: the first at about 12–15 months and a second around 4–6 years old. This second dose helps ensure long-lasting immunity across the population, particularly since some individuals may not respond fully to the first dose. For tetanus, booster doses are given every 10 years (Td or Tdap), with a booster recommended sooner if a significant wound occurs and vaccination status isn’t up to date. This keeps protective antibody levels high, since tetanus immunity can wane over time. So, the idea that it mainly stimulates mucosal immunity, yields lifelong immunity with no boosters, and spares boosters altogether doesn’t align with how these vaccines work and how their schedules are designed.